According to Swedish Orphan Biovitrum's latest financial reports the company's current revenue (TTM ) is S$3.23 Billion. an increase over the revenue in the year 2023 that were of S$2.78 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 | S$3.34 B | 20.1% |
2023 | S$2.78 B | 12.37% |
2022 | S$2.47 B | 3.76% |
2021 | S$2.38 B | 7.24% |
2020 | S$2.22 B | 8.97% |
2019 | S$2.04 B | 44.09% |
2018 | S$1.41 B | 36.62% |
2017 | S$1.03 B | 17.7% |
2016 | S$0.88 B | 62.25% |
2015 | S$0.54 B | 11.24% |
2014 | S$0.48 B | 15.31% |
2013 | S$0.42 B | 19.71% |
2012 | S$0.35 B | -6.33% |
2011 | S$0.37 B | 9.37% |
2010 | S$0.34 B | 42.12% |
2009 | S$0.24 B |